BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 8624866)

  • 1. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.
    Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ
    Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
    Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R
    Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction.
    Zoni-Berisso M; Molini D; Mela GS; Vecchio C
    Am J Cardiol; 1996 Apr; 77(9):673-80. PubMed ID: 8651115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone: clinical trials.
    Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
    Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.
    Schläpfer J; Rapp F; Kappenberger L; Fromer M
    J Am Coll Cardiol; 2002 Jun; 39(11):1813-9. PubMed ID: 12039497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
    Fleurant E; Lacroix D; Klug D; Warembourg H; Kacet S; Lekieffre J
    Arch Mal Coeur Vaiss; 1996 Apr; 89(4):435-44. PubMed ID: 8763003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
    Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
    Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
    Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
    Olson PJ; Woelfel A; Simpson RJ; Foster JR
    Am J Cardiol; 1993 Apr; 71(10):823-6. PubMed ID: 8456761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
    Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction.
    Rodriguez LM; Smeets J; O'Hara GE; Geelen P; Brugada P; Wellens HJ
    Am J Cardiol; 1992 Jun; 69(17):1403-6. PubMed ID: 1590227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
    Bourret N; Kirkorian G; Chevalier P; Bellon C; Richalet C; Bouchayer D; Bonnefoy E; Touboul P
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy].
    Zehender M; Faber T; Furtwängler A; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1992 Dec; 81(12):704-9. PubMed ID: 1492440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.